Leveraging CRISPR: Identification of Essential Proliferation & Trametinib Resistance Mechanisms in Uveal Melanoma
Time: 1:15 pm
day: Day One
Details:
- Leveraging CRISPR to identify novel genetic dependencies
- Validation of CRISPR screening hits
- Using CRISPR screening results to guide pharmacological targeting of essential mechanisms
Rich Bennett" alt="Rich Bennett" itemprop="image">